logo

ICCC

Immucell·NASDAQ
--
--(--)
--
--(--)

ICCC fundamentals

Immucell (ICCC) expects to report earnings on May 12, 2022, with estimated revenue of -- (YoY --), and EPS at -- (YoY --).
Revenue estimate / YoY
--
--
EPS estimate / YoY
--
--
Report date
May 12, 2022
EPS
Q1,2018
Q2,2018
Q3,2018
Q4,2018
Q1,2019
Q2,2019
Q3,2019
Q4,2019
Q1,2020
Q2,2020
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Actual
-0.02-0.11-0.040.03-0.060.020.02-0.01
Forecast
-0.1-0.08-0.040.05-0.08-0.06-0.01
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-10.00%
+50.00%
+175.00%
-220.00%
+125.00%
+133.33%
0.00%
0.00%
Revenue
Q1,2018
Q2,2018
Q3,2018
Q4,2018
Q1,2019
Q2,2019
Q3,2019
Q4,2019
Q1,2020
Q2,2020
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Actual
----------------4.91M2.97M--3.74M4.11M4.54M5.20M5.40M--
Forecast
------------------3.00M3.27M4.00M5.40M3.26M3.59M5.40M--
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-1.13%
0.00%
-6.33%
-23.96%
+39.20%
+44.69%
0.00%
0.00%

Earnings Call